Vitamin d, adiposity, and calcified atherosclerotic plaque in african-americans
- PMID: 20061416
- PMCID: PMC2841532
- DOI: 10.1210/jc.2009-1797
Vitamin d, adiposity, and calcified atherosclerotic plaque in african-americans
Abstract
Context: Inverse associations are reported between circulating 25-hydroxyvitamin D and visceral adiposity. The effects of vitamin D levels on atherosclerosis are unknown.
Objective: The objective of this study was to test for relationships between vitamin D, adiposity, bone density, and atherosclerosis in African-Americans.
Design: Circulating 25-hydroxyvitamin D, 1,25 dihydroxyvitamin D, intact PTH, C-reactive protein and computed tomography-derived calcified atherosclerotic plaque (CP), bone density, and fat volumes were measured.
Setting: Examinations were performed at a single outpatient general clinical research center visit.
Subjects: Three hundred forty African-Americans with type 2 diabetes were evaluated. Mean +/- SD age was 55.6 +/- 9.6 yr, diabetes duration 10.6 +/- 8.3 yr, glomerular filtration rate 1.6 +/- 0.5 ml/sec, body mass index 35.6 +/- 8.7 kg/m(2), and 25-hydroxyvitamin D concentration 50.4 +/- 30.5 nmol/liter.
Main outcome measure: Biomarkers were tested for association with pericardial, visceral, im, and sc adipose tissues; thoracic and lumbar vertebral bone density; and aorta, coronary, and carotid artery CP.
Results: Adjusting for age, gender, body mass index, glycosylated hemoglobin, and glomerular filtration rate, 25-hydroxyvitamin D was negatively associated with visceral adiposity (P = 0.009) and positively associated with carotid artery CP and aorta CP (P = 0.013 and 0.014, respectively) but not with coronary artery CP or bone density.
Conclusions: We confirmed an inverse association between vitamin D and visceral adiposity in African-Americans with diabetes. In addition, positive associations exist between 25-hydroxyvitamin D and aorta and carotid artery CP in African-Americans. The effects of supplementing vitamin D to raise the serum 25-hydroxyvitamin D level on atherosclerosis in African-Americans are unknown. Prospective trials are needed to determine the cardiovascular effects of supplemental vitamin D in this ethnic group.
Figures
References
-
- Luckey MM, Wallenstein S, Lapinski R, Meier DE 1996 A prospective study of bone loss in African-American and white women—a clinical research center study. J Clin Endocrinol Metab 81:2948–2956 - PubMed
-
- Acheson LS 2005 Bone density and the risk of fractures: should treatment thresholds vary by race? JAMA 293:2151–2154 - PubMed
-
- Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC 2003 Time trends in reported prevalence of kidney stones in the United States: 1976–1994. Kidney Int 63:1817–1823 - PubMed
-
- Aloia JF, Patel M, Dimaano R, Li-Ng M, Talwar SA, Mikhail M, Pollack S, Yeh JK 2008 Vitamin D intake to attain a desired serum 25-hydroxyvitamin D concentration. Am J Clin Nutr 87:1952–1958 - PubMed
-
- Bild DE, Detrano R, Peterson D, Guerci A, Liu K, Shahar E, Ouyang P, Jackson S, Saad MF 2005 Ethnic differences in coronary calcification: the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation 111:1313–1320 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous